Arbuckle Stuart A Insider Trades

Insider Trading History

Track insider trading activity for Arbuckle Stuart A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Praxis Precision Medicines
Praxis Precision Medicines PRAX
Director
Holding Value $775k 2,537 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$486k 2,019 shares
$240.66
$305.37
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $415k 1,441 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$630k 2,112 shares
$298.48
$288.18
Praxis Precision Medicines
Praxis Precision Medicines PRAX
Director
Holding Value $356k 1,166 shares
Last Trade
Feb 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$444k 1,390 shares
$319.57
$305.37
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $945k 3,279 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 3,279 shares
$397.83
$288.18
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $29.7M 63,368 shares
Last Trade
Jul 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.8M 37,243 shares
$450.23
$468.28
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $747k 7,037 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$448k 7,037 shares
$63.66
$106.19
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $743k 7,000 shares
Last Trade
Jun 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 4,000 shares
$61.48
$106.19
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $0 0 shares
Last Trade
Jun 18, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 4,000 shares
$61.48
$106.19
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $47.1M 100,611 shares
Last Trade
May 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.3M 37,622 shares
$432.00
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $29.5M 62,935 shares
Last Trade
Feb 26, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.39M 7,071 shares
$479.61
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $32.8M 70,006 shares
Last Trade
Feb 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.28M 4,716 shares
$483.28
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $35M 74,722 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.26M 2,724 shares
$463.46
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $36.3M 77,446 shares
Last Trade
Feb 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.58M 7,903 shares
$453.20
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $32.6M 69,543 shares
Last Trade
Feb 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.51M 3,220 shares
$467.98
$468.28
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $0 0 shares
Last Trade
Jun 21, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 3,000 shares
$41.87
$106.19
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $319k 3,000 shares
Last Trade
Jun 21, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 3,000 shares
$41.87
$106.19
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $1.49M 14,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$579k 14,000 shares
$41.39
$106.19
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $23.3M 49,691 shares
Last Trade
May 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$29.7k 69 shares
$430.93
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $23.3M 49,691 shares
Last Trade
Feb 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.14M 5,034 shares
$425.70
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, COO
Holding Value $25.6M 54,725 shares
Last Trade
Feb 23, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.04M 4,714 shares
$431.79
$468.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up